← Open Payments lookup

JOSEPH MASCARO: Open Payments

NPI 1841834710 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$817 in 35 payments from 11 companies in 2025. Trend: 2023 $839 · 2024 $688 · 2025 $817

Food & beverage: $817
CompanyPaymentsAmount
Novo Nordisk Inc11$249
Boehringer Ingelheim Pharmaceuticals, Inc.5$149
Alnylam Pharmaceuticals Inc.5$107
Amgen Inc.3$74
E.R. Squibb & Sons, L.L.C.3$56
United Therapeutics Corporation2$49
AstraZeneca Pharmaceuticals LP2$41
SCPHARMACEUTICALS INC.1$31
GlaxoSmithKline, LLC.1$24
Novartis Pharmaceuticals Corporation1$21

Products named: Wegovy, JARDIANCE, ONPATTRO, REPATHA, CAMZYOS, Tyvaso, FARXIGA, Ozempic.

Industry payments across PA — which companies pay providers there.